A novel substance purified from Perilla frutescens Britton inhibits an early stage of HIV-1 replication without blocking viral adsorption

Antiviral Chemistry and Chemotherapy

Volumn 13, Issue 5, 2002, Pages 283-288

  Kawahata, T ^a,b   Otake, T ^b   Mori, H ^b   Kojima, Y ^b   Oishi, I ^b   Oka, S ^c   Fukumori, Y ^d   Sano, K ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^c NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^d Hokuren Fed of Agric Cooperatives   (Japan)

Author keywords

Antiviral; HIV; Perilla frutescens; Viral entry

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; DEXTRAN SULFATE; GLYCOPROTEIN; LAMIVUDINE; PERILLA FRUTESCENS EXTRACT; PLANT EXTRACT; PROTEIN PF GP6; SAQUINAVIR; STAVUDINE; UNCLASSIFIED DRUG; VIRUS DNA; ZIDOVUDINE;

ARTICLE; DISEASE COURSE; DISEASE SEVERITY; DNA SYNTHESIS; DRUG ISOLATION; DRUG PURIFICATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IC 50; IN VITRO STUDY; NONHUMAN; PERILLA FRUTESCENS; PHYTOTHERAPY; PLANT; PRIORITY JOURNAL; VIRUS ADSORPTION; VIRUS INACTIVATION; VIRUS INHIBITION; VIRUS PARTICLE; VIRUS STRAIN;

EID: 0038007946     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020201300503     Document Type: Article

References (20)

1. Adachi A, Gendelman HE, Koenig S, Forks T, Willey R, Rabson A & Martin MA (1986) Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. Journal of Virology 59:284-291.
2. Asada M, Fukumori Y, Inoue M, Nakagomi K, Sugie M, Fujita Y, Tomisuka N, Yamazaki Y & Oka S (1999) Glycoprotein derived from the hot water extract of mint plant, Perilla frutescens Britton. Journal of agricultural and Food Chemistry 47:468-472.
3. Calabrese C, Berman SH, Babish JG, Ma X, Shinto L, Dorr M, Wells K, Wenner CA & Standish LJ (2000) A phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytotherapy Research 14:333-338.
4. De Clercq E, Yamamoto N, Pauwels R, Baba M, Schols D, Nakashima H, Balzrini J, Murrer BA, Schwartz D, Thornton D, Bridger G, Fricker S, Henson G, Abrams M & Picker D (1992) Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event. Proceedings of the National Academy of Sciences USA 89:5286-5290.
5. Doranz BJ, Grovit-Ferbas K, Sharron MP, Mao SH, Goetz MB, Daar ES, Doms RW & O'Brien WA (1997) A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. Journal of Experimental Medicine 186:1395-1400.
6. Dragic T, Trkola A, Thompson DA, Cormier EG, Kajumo FA, Maxwell E, Lin SW, Ying W, Smith SO, Sakmar TP & Moore JP (2000) A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proceedings of the National Academy of Sciences USA 97:5639-5644.
7. El-Mekkawy S, Meselhy MR, Nakamura N, Tezuka Y, Hattori M, Kakiuchi N, Shimotohno K, Kawahata T & Otake T (1998) Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. Phytochemistry 49:1651-1657.
8. Kimpton J & Emerman M (1992) Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. Journal of Virology 66:2232-2239.
9. Koyanagi Y, Miles S, Mitsuyasu RT, Merrill JE, Vinters HV & Chen ISY (1987) Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819-822.
10. Larder BA, Darby G & Richman DD (1989) HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science. 243:1731-1734.
11. Martin I, Turco SJ, Epand RM & Ruysschaert JM (1998) Lipophosphoglycan of Leishmania donovani inhibits lipid vesicle fusion induced by the N-terminal extremity of viral fusogenic simian immunodeficiency virus protein. European Journal of Biochemistry 258:150-156.
12. Matsushita S, Robert Guroff M, Rusche J, Koito A, Hattori T, Hoshino H, Javaherian K, Takatsuki K & Putney S (1988) Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. Journal of Virology 62:2107-2114.
13. Otake T, Mori H, Morimoto M, Ueba N, Kunita N, Sano K, Nakai M, Okubo S, Yasunaga K, Nagao N, Hirai K & Okubo Y (1990) HIV isolation and clinical markers on the seropositive subjects. Kansenshogaku Zasshi 64:1287-1294.
14. Otake T, Mori H, Morimoto M, Miyano K, Ueba N, Oishi I, Kunita N & Kurimura T. (1999) Anti-HIV-1 activity of myo-inositol hexaphosphoric acid (IP6) and myo-inositol hexasulfate (IS6). Anticancer Research 19:3723-3726.
15. Rusconi S, La-Seta-Catamancio S, Kurtagic S, Galazzi M, Arienti D, Trabattoni D, Wilken J, Thompson DA, Offord RE, Galli M & Clerici M (1999) Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon g to interleukin 10 ratio without impairing cellular proliferation. AIDS Research and Human Retroviruses 15:861-867.
16. Schols D, Este JA, Henson G & De Clercq E (1997) Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV co-recep- tor Fusin/CXCR-4. Antiviral Research 33:147-156.
17. Starcich BR, Hahn BH, Shaw GM, McNeely PD, Modrow S, Wolf H, Parks ES, Parks WP, Josephs SF, Gallo RC & Wong-Staal F (1986) Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell 45:637-648.
18. Wong JK, Gunthard HF, Havlir DV, Zhang ZQ, Hasse AT, Ignacio CC, Kwok S, Emini E & Richman DD (1997) Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proceedings of the National Academy of Sciences USA 94:12574-12579.
19. Wyatt R & Sodroski J (1998) The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280:1884-1888.
20. Yamasaki K, Nakano M, Kawahata T, Mori H, Otake T, Ueba N, Oishi I, Inami R, Yamane M, Nakamura M, Murata H & Nakanishi T (1998) Anti-HIV-1 activity of herbs in Labiatae. Biological and Pharmaceutical Bulletin 21:829-833.